Iliac Aneurysms Global Clinical Trials Review, H1, 2012

Iliac Aneurysms Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Iliac Aneurysms Global Clinical Trials Review, H2, 2011" provides data on the Iliac Aneurysms clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Iliac Aneurysms. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Iliac Aneurysms. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Contents

Table of Contents
List of Tables
List of Figures
Introduction
Iliac Aneurysms
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Trial Status
Unaccomplished Trials of Iliac Aneurysms
Subjects Recruited Over a Period of Time
Prominent Sponsors
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Cook
Clinical Trial Overview of Cook
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Maxima Medical Center
Clinical Trial Overview of Maxima Medical Center
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Iliac Aneurysms Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Iliac Aneurysms Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Iliac Aneurysms Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Iliac Aneurysms Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012*
Iliac Aneurysms Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Iliac Aneurysms Therapeutics Clinical Trials, North America, Top Countries, 2012*
Iliac Aneurysms Therapeutics Clinical Trials, BRIC Countries, 2012*
Iliac Aneurysms Therapeutics Clinical Trials, G7 Countries, 2012*
Iliac Aneurysms Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Iliac Aneurysms Therapeutics Clinical Trials, E7 Countries, 2012*
Iliac Aneurysms Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Iliac Aneurysms Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Iliac Aneurysms Therapeutics Market, Global, Terminated Clinical Trials, 2012*
Iliac Aneurysms Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Iliac Aneurysms Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Iliac Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Cook, 2012*
Iliac Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Maxima Medical Center, 2012*

LIST OF FIGURES

Iliac Aneurysms Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Iliac Aneurysms Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Iliac Aneurysms Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Iliac Aneurysms Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012*
Iliac Aneurysms Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
Iliac Aneurysms Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Iliac Aneurysms Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Iliac Aneurysms Therapeutics Clinical Trials, G7 Countries (%), 2012*
Iliac Aneurysms Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Iliac Aneurysms Therapeutics Clinical Trials, E7 Countries (%), 2012*
Iliac Aneurysms Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Iliac Aneurysms Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Iliac Aneurysms Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Iliac Aneurysms Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
GlobalData Methodology Skip to top